P2.5 The identification of a viable outcome measure in the collagen VI myopathies promotes progress toward clinical trials - Foley, A.R.; Quijano-Roy, S.; Collins, J.; Straub, V.; Deconinck, N.; Mercuri, E.; D’Amico, A.; Bertini, E.; North, K.; Ryan, M.; Rummey, C.; Meier, T.; et al. (Neuromuscular Disorders, 2011)